Home > Insider Trading > Filing (0001209191-18-049379)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1619087	Steadymed Ltd.	STDY	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1637025	Steadymed Investors, Llc	C/O Steadymed Ltd. 2603 Camino Ramon, Suite 350 San Ramon CA 94583		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2018-08-30	266,257	$4.46	No	4	S	Indirect	See Footnote.
Ordinary Shares	Disposition	2018-08-30	2,088,258	$4.46	No	4	S	Indirect	See Footnote.
Ordinary Shares	Disposition	2018-08-30	181,025	$4.46	No	4	S	Indirect	See Footnote.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote.
No	4	S	Indirect	See Footnote.
No	4	S	Indirect	See Footnote.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Warrants to Purchase Ordinary Shares	Disposition	2018-08-30	266,257	$0.13	266,527	$3.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-08-03	No	4	J	Indirect

Footnotes

Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation ("United"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the "Merger Agreement"). Under the Merger Agreement, at the effective time of the merger (the "Effective Time"), each outstanding ordinary share of the Issuer was converted into the right to receive (1) $4.46 in cash plus (2) one contractual contingent value right (a "CVR"), which represents the right to receive $2.63 in cash upon the achievement of a specified milestone (the "Milestone").
By SteadyMed Investors III LLC, an affiliate of SteadyMed Investors, LLC.
By SteadyMed Investors, LLC. KB Partners, LLC is the Managing Member and the Reporting Person is the Managing Member of KB Partners, LLC.
By SteadyMed Investors II, LLC, an affiliate of SteadyMed Investors LLC.
Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation ("United"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the "Merger Agreement"). At the Effective Time, each outstanding warrant to purchase ordinary shares of the Issuer issued in 2016 was converted into the right to receive $2.71.